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Cell surface glycosylation patterns are markers of cell type and status. However, the mechanisms
regulating surface glycosylation patterns remain unknown. Using a panel of carbohydrate markers,
we have shown that cell surface sialylation and fucosylation are upregulated in L1-transfected
embryonic stem cells (L1-ESCs). Consistently, the mRNA levels of sialyltransferase ST6Gal1 and
ST3Gal4, and fucosyltransferase FUT9 were signiﬁcantly increased in L1-transfected ESCs. Activation
of L1 signaling promoted cell survival and inhibited cell proliferation. ShRNAs knocking down FUT9,
ST6Gal1 and ST3Gal4 blocked these effects. A phospholipase Cc (PLCc) inhibitor and shRNA reduced
ST6Gal1, ST3Gal4 and FUT9 mRNA levels in the L1-ESCs. Thus, embryonic stem cell surface sialylation
and fucosylation are regulated via PLCc by L1, with which they cooperate to modulate cell survival
and proliferation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cell recognition molecules at the cell surface are both donors
and acceptors of carbohydrates. These carbohydrates mediate
interactions between recognition molecules in cis or trans and
thereby modulate their functions as receptors at the cell surface
and as signal transducers [1]. For instance, the cell recognition
molecule, L1, a member of the immunoglobulin superfamily, is
one of many carbohydrate-carrying molecules in the nervous sys-
tem, where it is widely expressed and involved in many aspects of
neural development, regeneration and synaptic plasticity in thechemical Societies. Published by E
, R&D China, Building 3, 898
ai 201203, China. Fax: +86 (0)
o).adult [2]. Various human genetic disorders with prominent ner-
vous system defects are caused by mutations in L1 [3]. L1 speciﬁ-
cally recognizes 2,3-linked sialic acids present on the cell surface
mucin, CD24, a heavily glycosylated cell surface molecule [1,4]. Re-
cently, using a murine embryonic stem cell line constitutively
expressing L1 at all stages of neural differentiation, we have shown
decreased cell proliferation in vitro, enhanced neuronal differenti-
ation in vitro and in vivo, and an increased yield of GABAergic neu-
rons and enhanced migration of embryonic stem cell-derived
neural precursor cells into the lesioned striatum in an in vivo ani-
mal model [5]. However, the molecular mechanisms by which L1
contributes to these processes remain unknown.
Glycosylation, a crucial event dominating post- or co-transla-
tional modiﬁcations [6], contributes to the functional diversity re-
quired to generate extensive phenotypes from a limited genotype
[7]. In most congenital diseases of glycosylation, defects inlsevier B.V. All rights reserved.
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or other neuropathological symptoms [1]. Fucosylated carbohy-
drate structures play important roles in a variety of biological
and pathological processes, such as tissue development, angiogen-
esis, fertilization, selectin-mediated leukocyte-endothelial adhe-
sion, inﬂammation, host immune response, and tumor metastasis
[8]. In mammals, alterations in the expression of fucosylated oligo-
saccharides occur in several pathological processes, including can-
cer and atherosclerosis [9]. Sialic acids are one of the most
important monosaccharides. They are expressed as terminal sugars
with a shared nine-carbon backbone in several classes of cell sur-
face and secreted glycan molecules [10]. In addition to providing
negative charge and hydrophilicity to vertebrate cell surfaces, to
masking subterminal galactose residues from recognition by cer-
tain receptors, and to acting as receptors for pathogens and toxins,
sialic acids play an important role during development, including
early embryonic development in mice [11].
In the present study, we have demonstrated that the cell recog-
nition molecule L1 modulates both sialylation and fucosylation on
embryonic stem cell surfaces through increased mRNA expression
of the glycosyltransferases ST6Gal1, ST3Gal4 and FUT9. Glycosyl-
transferase induction by L1 requires phospholipase Cc and inﬂu-
ences cell survival and proliferation.2. Materials and methods
2.1. Antibodies, lectins and inhibitors
Goat polyclonal anti-mouse, rat and human FUT9 antibody and
goat polyclonal anti-mouse, rat and human ST3Gal4 antibody were
purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA,
USA). Mouse monoclonal anti-human ST6Gal1 antibody was pur-
chased from Chemicon International Inc. (Temecula, CA, USA). Rab-
bit polyclonal anti-mouse, rat and human PLCc antibody was
purchased from Cell Signaling Technology Inc. (Danvers, MA,
USA). The monoclonal anti-mouse L1 antibody 557 was produced
and puriﬁed as previously described [12]. Anti-SSEA-1 antibody
was purchased from Santa Cruz Biotechnology Inc. Rat anti-mouse
IgM-microbeads and LS+ positive selection columns were pur-
chased from Miltenyi Biotec Inc. (Miltenyi Biotec. Inc., Bergisch
Gladbach, Germany). L3, L4 and L5 antibodies were produced as
previously described [13–16]. R-Phycoerythin (R-PE)-conjugated
mouse anti-rat monoclonal, PerCP-CY5.5-conjugated rat anti-
mouse IgM monoclonal and R-PE-conjugated rat anti-mouse IgM
monoclonal antibodies were purchased from BD Biosciences
(Franklin Lakes, NJ, USA). Biotinylated lectins and Texas Red avidin
D were purchased from Vector Laboratories, Inc. (Burlingame, CA,
USA). Inhibitors were either from Calbiochem, San Diego, CA, USA
(U73122, Cdc25 phosphatase inhibitor II, and Erk inhibitor) or from
Sigma, St. Louis, MO, USA (LY294002 and KT5720). Leukemia inhib-
itory factor (LIF) was purchased from Chemicon International Inc.
2.2. Cell culture
All cell culture reagents were purchased from Invitrogen Life
Technologies (Merelbeke, Belgium) unless indicated otherwise.
Murine embryonic stem cells (ESCs) stably transfected with L1
were generated at the laboratory of M. Schachner as previously de-
scribed [17]. They were cultured in ES-DMEM supplemented with
15% ES-FBS, 1 non-essential amino acids, 20 mM L-glutamine,
0.5 U/mL penicillin, 0.5 U/mL streptomycin, and 0.1 mM 2-mercap-
toethanol. Undifferentiated ES cells were grown on mitomycin C-
treated murine embryonic ﬁbroblasts (MEFs) in the presence of
1000 U/mL leukemia inhibitory factor (LIF; Chemicon Inc.). ES cells
were passaged every 2 or 3 days using 0.05% trypsin/0.04% EDTAfor 2–3 min. The ﬂow cytometry assay was performed using rou-
tinely maintained adherent mouse ESC colonies. The NIH3T3 cells
were maintained in DMEM supplemented with 10% FBS, 0.5 U/
mL penicillin, 0.5 U/mL streptomycin. Cells were passaged every
2 or 3 days using 0.05% trypsin/0.04% EDTA. The single cells ob-
tained were used for ﬂow cytometry assay.
2.3. Enrichment of SSEA-1 positive murine embryonic stem cells (ESCs)
Murine ESCs were grown in 10 cm dishes and passaged into sin-
gle cell suspensions as described above. Cells were incubated at
4 C for 30 min in a 1:10 dilution of SSEA-1 antibody in D/G buffer.
D/G buffer consisted of 0.5% BSA and 2 mM EDTA in phosphate buf-
fered saline (PBS), pH7.4. After incubation, 10 ml D/G buffer was
added and the cells were re-suspended and centrifuged at 300g
for 5 min. The supernatant was removed, leaving the cell pellet in-
tact, and cells were washed again in D/G buffer and re-suspended.
Following centrifugation, a 1:4 dilution of secondary anti-mouse
IgM-beads in D/G buffer was added to the cell pellet, and the re-
suspended pellet was incubated at 4 C for 5 min. After incubation,
10 ml D/G buffer was added to wash the cell pellet, followed by
centrifugation (300g) for 5 min. This process was repeated two
more times with 5 ml D/G buffer. The cells were ﬁnally re-sus-
pended in 500 ll of D/G buffer before being applied to a pre-
washed magnetic beads column. The ﬂow-through from the col-
umn was collected and re-applied to the magnetic beads column
three times. Then, 5 ml D/G buffer was applied to the magnetic
beads column to obtain the eluate. The eluate was collected, and
the cell number was counted. The SSEA-1 positive cell enriched
populations were then used for the subsequent experiments.
2.4. Flow cytometric analysis of surface expression of carbohydrates
Cell surface carbohydrate expression was assessed by indirect
immunoﬂuorescence detection using a ﬂow cytometer, FACSCali-
bur (Becton-Dickinson, San Jose, USA) equipped with an argon la-
ser with emission wavelength at 488 nm. Flow cytometry results
presented here are from mESCs that were used immediately after
the SSEA-1 positive cell enrichment procedure. CellQuest Pro soft-
ware (Becton-Dickinson) was used for cell acquisition and analysis.
Embryonic stem cells were prepared and cultured as described
above. The cells were digested with 0.05% trypsin and washed
twice with PBS (Gibco, Long Island, USA). Single cell suspension
was prepared in PBS with 10%FBS with the concentration adjusted
to 107 cells/ml for indirect antibody labeling. Antibody labelings of
the cells were carried out using 4 ml sterile tubes (Falcon, Becton-
Dickison). In brief, 50 ll of cell suspension (5  105 cells) was ali-
quoted into 4 ml sterile centrifuge tubes (Falcon) and incubated
with (amount = 1 lg) primary antibodies against the 14 carbohy-
drates and lectins in PBS with 10%FBS for 30 min at 4 C in the
darkness. Cells were washed 3 times with chilled PBS and then
incubated with secondary antibody conjugated with R-phycoery-
thin or Peridinin chlorophyll protein (R-PE or Per-CP, 1 lg) in
50 ll of PBS with 10% FBS for further 30 min at 4 C in the darkness.
Cells were washed three times with chilled PBS, ﬁxed in PBS with
1% formaldehyde (Sigma) and kept at 4 C in the darkness before
ﬂow cytometric analysis. 104 cells from each tube were acquired
for analysis. Unstained cells and cells stained with secondary anti-
body alone were used as controls for autoﬂuorescence.
2.5. Microarray analysis
Procedures for cDNA synthesis, labeling, and hybridization were
carried out in accordance with the manufacturer’s protocol
(Affymetrix Inc., Santa Clara, CA, USA). All experiments were per-
formed using Affymetrix mouse genome Genechip 430 2.0 arrays.
Fig. 1. Activation of L1 promotes embryonic stem cell (ESC) survival and inhibits
ESC proliferation. (A) To investigate the role of L1 in ESC survival, MTT analysis was
performed. Mouse ESC survival was signiﬁcantly enhanced in the L1-transfected
ESCs (L1-ESCs) versus control ESCs. (B) To investigate the role of L1 in cell
proliferation, BrdU incorporation method was performed. ESC proliferation was
signiﬁcantly inhibited in the L1-transfected ESCs (L1-ESCs) versus control ESCs.
*P < 0.05, by Student’s t-test.
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with a high-performance liquid chromatography puriﬁed T7-(dT)
24 primer. Synthesis of biotinlabeled cRNA was carried out using
the ENZO RNA transcript labeling kit (Affymetrix). For hybridiza-
tion, 15 lg fragmented cRNA were incubated with the chip in
200 ll hybridization solution in a Hybridization Oven 640 (Affyme-
trix) at 45 C for 16 h. Genechips were washed and stained with
streptavidin–phycoerythrin using the microﬂuidic workstationTM
(Affymetrix) and scanned with Affymetrix Microarray scanner sys-
tem. Data were analyzed using Spotﬁre software (Somerville, MA,
USA).
2.6. Real-time PCR
To compare the transcript levels, total RNA from embryonic
stem cells was isolated using an RNeasy mini kit (Qiagen, Valencia,
CA, USA). Total RNA concentration was determined using a spec-
trophotometer by measuring absorption at 260 nm and 280 nm
wavelengths. To check RNA integrity, total RNA was separated in
a 1% agarose gel containing formaldehyde and stained with ethi-
dium bromide. Reverse transcription was performed with the
SuperScriptTM First-strand Synthesis System for RT-PCR Kit (Invit-
rogen, Carlsbad, CA, USA), in accordance with the manufacturer’s
protocol. Brieﬂy, 5 lg total RNA was reverse transcribed with ran-
dom hexamers. First-strand reverse transcribed cDNA was then di-
luted 1:10 in water before use for real-time PCR. cDNA was
subjected to real-time PCR using the 7000 ABI Detection System
(Applied Biosystems, Foster City, CA, USA). Real-time PCR reactions
(Applied Biosystems) included 1 TaqMan Universal PCR master
mix, 1 Assays-on-Demand TM Gene Expression Assay Mix, and
2 ll of template in a 20 ll reaction volume. The following program
was run: 50 C for 30 min, 95 C for 15 min, then 40 cycles of 94 C
for 15 s, 60 C for 1 min, followed by plate reading. The assay ID
number of Fut9 is Mm01223272_m1; the assay ID number of
St6gal1 is Mm00486119_m1; the assay ID number of St3gal4 is
Mm00501503_m1. Gapdh was used as reference, and its assay ID
number is Mn99999915_g1.
2.7. Cell survival measurement (MTT assay)
The cells were cultured in 96 well plates for 24 h. Afterwards,
10 ll 5 mg/mL MTT solution was then added and cells were cul-
tured at 37 C for 4 h. After washing with PBS, 20% SDS in PBS
was added to lyse the cells and dissolve the dye crystals. The absor-
bance at 570 nm was determined with an El800 universal micro-
plate reader (BioTek Instruments Inc., Winooski, VT, USA) and the
percentage of surviving cells was calculated [18].
2.8. Cell proliferation assay
2.8.1. 5-Bromo-20-deoxyuridine incorporation method
Cell proliferation was measured by incorporation of 5-bromo-
20-deoxyuridine (BrdU) (Roche Diagnostics GmbH, Mannheim, Ger-
many) into the genomic DNA during the S phase of the cell cycle.
Cells were incubated and processed with the BrdU Labeling and
Detection Kit III (Roche Diagnostics GmbH, Mannheim, Germany)
according to the manufacturer’s protocol. Cells were stained with
BrdU, anti-BrdU-PODS, and peroxidase substrate. Cells from the
same population that were not BrdU-labeled were used as negative
control. Absorbance at 405 nm was measured and compared using
an ELISA plate reader ﬂuorometer (Spectraﬂuor, TECAN, USA);
Magellan software was used for analysis.
2.8.2. mRNA knockdown using short hairpin RNAs (shRNAs)
Isolated ES cells ((3–4)  106) were combined with 2 lg respec-
tive shRNA vector or an empty control vector (control group) and100 ll ES cells-speciﬁc Nucleofector solution (Amaxa, Cologne,
Germany), then transferred to an Amaxa-certiﬁed cuvette. Electro-
poration was performed according to Amaxa Nucleofection proto-
col with the Amaxa NucleofectorTM II device and the mouse ESCs A-
030 program [19]. After transfection, cells were transferred into
culture dishes using the culture medium described above.
Twenty-four hours later, cells were used for MTT assay and prolif-
eration assay. For NIH-3T3 cell transfection, 100 ll cell line-spe-
ciﬁc Nucleofector solution (Amaxa), vector and NIH3T3 cells
were mixed. The U-030 program was used for transfection with
the Amaxa NucleofectorTM II device as described for the transfec-
tion of embryonic stem cells. For culturing, DMEM medium was
used as described above.
2.9. Western blot analysis
Immunoblotting was performed as described [5]. Transfected
NIH3T3 cells were lysed with RIPA buffer (1% NP-40, 0.5% sodium
deoxycholate, 0.25% SDS, 0.15 M NaCl, 0.01 M sodium-phosphate,
2 mM EDTA, 50 mM sodium ﬂuoride, 1 mM sodium orthovanadate,
0.5 mM PMSF, 10 lg/ml aproptinin and leupeptin) [20]. Protein
concentration was determined by the Bio-Rad BCA assay. Samples
containing equal amounts of protein were resolved by SDS–PAGE
and transferred to polyvinylidene diﬂuoride (PVDF) membranes
(Millipore), followed by incubation with primary and secondary
antibodies and chemiluminescent detection using the ECL kit
(Amersham Biosciences Corp.). The following antibodies were used
in this study: FUT9, ST6Gal1 and St3Gal4 (Santa Cruz Biotechnol-
ogy), PLCc1 (Cell Signaling Technology Inc., Danvers, MA, USA),
and b-actin (Sigma).
Fig. 2. Glycosylation patterns on the cell surface of ESCs and L1-transfected ESCs. Murine embryonic stem cells (ESCs) and L1-transfected ESCs (L1-ESCs) were assayed by ﬂow
cytometry using a panel of carbohydrate surface markers, including lectins and antibodies against carbohydrates. (A) SSEA-1 expression in enriched ESCs determined by ﬂow
cytometry. The histogram plots of unstained, control ESCs (left) and cells stained with SSEA-1 antibody after enrichment using magnetic bead sorting at day 0 (right). (B) In
the ﬂow cytometry histograms (above), the ﬁlled green areas show the number of unstained cells and the areas outlined in red represent cells binding to various lectins (SNA,
MAA, UEAI, PNA and JAC) and carbohydrates antibodies (L5). A quantitative analysis (bar graph, below) showed that the expression of carbohydrates recognized by SNA, MAA,
UEAI and PNA as well as L5 antibodies was signiﬁcantly increased in L1-ESCs versus control ESCs. *P < 0.05, **P < 0.001, by Student’s t-test. (C) The carbohydrate structures for
terminal sialylation (ﬁrst two rows from top) and fucosylation (bottom row) with related transferases are recognized by SNA, MAA, UEAI, and L5 antibodies on cell surfaces.
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All data were expressed as means ± S.E.M. Statistical evalua-
tions were achieved by one-way analysis of variance and Student’s
t-test. Differences were considered to be signiﬁcant when P < 0.05.
3. Results
3.1. L1. promotes survival and inhibits proliferation of embryonic stem
cells (ESCs)
L1 enhances neuronal survival [21,22]. Recently, we have also
shown that L1 decreases cell proliferation of embryonic stem cells
(ESCs) [5]. Thus, we investigated whether L1 plays a role in ESC
survival and proliferation. MTT analysis showed that cell survival
was signiﬁcantly enhanced in murine ESCs stably transfected with
L1 (L1-ESCs) (A570: 0.497 ± 0.011) versus untransfected ESCs (A570:
0.351 ± 0.013) (Fig. 1A). Next, using the 5-bromo-20-deoxyuridine
incorporation, we further conﬁrmed that cell proliferation was sig-
niﬁcantly reduced in L1-transfected ESCs (A570: 0.319 ± 0.031) ver-
sus ESCs (A570: 0.521 ± 0.035) (Fig. 1B).
3.2. L1. modulates expression of speciﬁc carbohydrates on the cell
surface of ESCs
Given that L1 is a carbohydrate-carrying molecule at the cell
surface and mediates interactions with itself or other adhesion
molecules, carbohydrate expression at the cell surface of ES cells
and ES cells transfected with L1 was analyzed by ﬂow cytometry
and the cell surface glycosylation patterns were compared. After
SSEA-1 (stage speciﬁc embryonic antigen 1) enrichment using
magnetic bead sorting, 99.92 ± 0.67% of isolated ESCs expressed
SSEA-1 (Fig. 2A). In the L1-ESCs, the expression of carbohydratesFig. 3. The mRNA expression of ST6Gal1, ST3Gal4 and FUT9 is modulated by L1. (A) cDNA
in the synthesis and hydrolysis of carbohydrates recognized by SNA, MAA, UEAI lectins a
(L1-ESC versus ESC group). Per group, two independent samples underwent microarray
versus ESC group (4.596-fold); b galactoside a 2,6 sialyltransferase (ST6Gal1) was elevate
(ST3Gal4) was elevated in L1-ESC versus ESC group (1.486-fold). (B) To verify the results o
of ST6Gal1, ST3Gal4 and FUT9 mRNAs was signiﬁcantly upregulated in the ESCs transferecognized with SNA, MAA, UEAI and PNA as well as L5 antibody
was signiﬁcantly upregulated (Fig. 2B). Both SNA and MAA recog-
nize terminal sialic acids, UEAI recognizes terminal fucose and L5
antibodies recognize LewisX, containing a terminal fucose residue
(Fig. 2C). Thus, these results demonstrate that L1 may play a role
in modulating the sialylation and fucosylation at ES cell surfaces.
3.3. L1. regulates the expression of the sialyltransferases ST6Gal1 and
ST3Gal4 and of the fucosyltransferase FUT9
Next, we investigated whether L1 could regulate the expression
of speciﬁc sialyltransferases and fucosyltransferases. To identify
the genes that respond to L1, cDNA microarray analysis was per-
formed to compare L1-ESCs and ESCs (L1-ESC versus ESC group,
Fig. 3A). Of 15 genes involved in the synthesis and hydrolysis of
carbohydrates examined, fucosyltransferase 9 (FUT9), galactoside
2, 6 sialyltransferase (ST6Gal1), and galactoside 2, 3 sialyltransfer-
ase (ST3Gal4) transcript levels were elevated in the L1-ESC versus
ESC group (4.596-fold, 1.231-fold, and 1.486-fold, respectively).
mRNA expression of UDP-Gal: GlcNAc 1,4 galactosyltrasferase
(B4GalT2) was strongly elevated as well. However, as this enzyme
is not involved in formation of the fucosylation or sialylation at the
end of carbohydrate structures, we did not focus on it. Real-time
PCR analysis conﬁrmed that mRNA levels of ST6Gal1, St3Gal4
and FUT9 were signiﬁcantly upregulated in L1-ESCs versus ESCs
(Fig. 3B). Thus, these results demonstrate that L1 upregulates the
expression of ST6Gal1, ST3Gal4 and FUT9 in ESCs.
3.4. ShRNA knocking down FUT9, ST6Gal1 and ST3Gal4 blocks the L1-
induced ESC survival and proliferation
To test the hypothesis that sialylation and fucosylation might be
involved in the L1-induced ESC survival and proliferation, wemicroarray analysis was performed to investigate the expression of genes involved
nd L5 antibody by comparing between L1-transfected ESCs and untransfected ESCs
analysis. The expression of fucosyltransferase 9 (FUT9) was elevated in the L1-ESC
d in L1-ESC versus ESC group (1.231-fold); and b galactoside a 2,3 sialyltransferase
btained by cDNA microarray analysis, real-time PCR was performed. The expression
cted with L1 (L1-ESC) versus ESCs. *P < 0.05, by Student’s t-test.
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cantly reduced the expression of either FUT9, ST6Gal1 or ST3Gal4
in transfected cells compared with their expression in empty vec-
tor transfected cells (Fig. 4A). To examine the impact of FUT9,
ST6Gal1 and ST3Gal4 on L1-enhanced cell survival, we performed
a MTT assay, demonstrating that enhancement of ESC survival by
L1 was abolished after treatment with shRNA against FUT9 or
ST6Gal1 or ST3Gal4 (Fig. 4B). A proliferation assay also showed
that ESC proliferation inhibited by L1 transfection was signiﬁcantly
increased after transfection with these shRNAs compared to their
respective control empty vector transfections (Fig. 4C). Together,
these results demonstrate that sialylation and fucosylation mayFig. 4. shRNAs of FUT9, ST6Gal1 and ST3Gal4 reversed ESC survival and prolifer-
ation induced by L1. (A) NIH3T3 cells were transfected with empty plasmid
(control: Cont) or shRNA of FUT9, ST3Gal4 or ST6Gal1 by electroporation. Twenty-
four hours later, cells were lysed and total protein was obtained. Western blotting
was used to detect the expression of FUT9, ST3Gal4 and ST6Gal1. (B) ESCs and L1-
ESCs were transfected with empty plasmid (control: Cont) or shRNA of FUT9,
ST3Gal4 or ST6Gal1, and seeded on coverslips. MTT analysis was performed to
detect cell survival. (C) ESC proliferation assay was performed in ESCs and L1-ESCs
transfected with empty plasmid (control: Cont) or shRNA of FUT9, ST3Gal4 or
ST6Gal1, BrdU incorporation relative to the ESC control group indicates relative cell
proliferation. *P < 0.05; by Student’s t-test.also contribute to the L1-induced modulation in cell survival and
proliferation.
3.5. L1-induced changes in FUT9, ST6Gal1 and ST3Gal4 mRNA levels
are dependent on phospholipase Cc
To understand the mechanism by which L1 induces changes in
sialylation and fucosylation, we blocked signal transduction path-
ways known to be activated by L1 and investigated the effects on
FUT9, STGGal1 and ST3Gal4 mRNA levels by real-time PCR. In ESCs
transfected with L1, treatment with the phospholipase Cc (PLCc)
inhibitor U73122 led to reduced FUT9, ST6Gal1 and ST3Gal4 mRNA
levels (Fig. 5A). In contrast, Cdc25 phosphatase (Cdc25) inhibitor II,
a phosphoinositide-3 kinase (PI3 K) inhibitor (LY294002) and a
protein kinase A inhibitor (KT5720) did not have consistent effects
on FUT9, STGGal1 and ST3Gal4 mRNA levels in L1-transfected ESCs
(Fig. 5A). Extracellular signal-regulated protein kinase (Erk) inhib-
itor increased FUT9, ST6Gal1 and ST3Gal4 mRNA levels (Fig. 5A).
The speciﬁcity of the PLCc inhibitor was not very high, so we used
a shRNA directed against PLCc, which signiﬁcantly reduced the
expression of PLCc in transfected cells compared with its expres-
sion in empty vector transfected cells (Fig. 5B). We found that
the shRNA against PLCc decreased the FUT9, STGGal1 and ST3Gal4
mRNA levels (Fig. 5B). Thus, together these data suggest that L1
regulates sialylation and fucosylation via a PLCc-dependent
pathway.4. Discussion
We have demonstrated that the cell recognition molecule L1 in-
creases sialylation and fucosylation via a PLCc-dependent path-
way. In turn, L1-dependent enhancement of cell survival and
inhibition of cell proliferation can be blocked by shRNAs directed
against the sialyltransferases STGGal1 and ST3Gal4 and against
the fucosyltransferase FUT9.
Using a murine embryonic stem cell line constitutively express-
ing L1 at all stages of neural differentiation, decreased cell prolifer-
ation in vitro, enhanced neuronal differentiation in vitro and in
vivo, and an increased yield of GABAergic neurons and enhanced
migration of embryonic stem cell-derived neural precursor cells
into the lesioned striatum have been previously shown in an
in vivo animal model [5]. In order to explore the mechanisms by
which L1 contributes to these processes, we have ﬁrst shown that
the cell surface expression of both sialic acid and fucose are signif-
icantly increased in ESCs in which L1 is overexpressed, further sug-
gesting that L1 plays a role in regulation of sialylation and
fucosylation on ESC surfaces. Consistently, we have demonstrated
that mRNA levels of ST6Gal1 and ST6Gal4, two sialyltransferases,
and FUT9, a fucosyltransferase, are signiﬁcantly upregulated in
L1-transfected ESCs using both cDNA microarray and real-time
PCR approaches. These ﬁndings suggest that L1 induces speciﬁc
carbohydrate expression patterns on stem cells.
Given that sialylation and fucosylation are enhanced at cell sur-
faces of the murine embryonic stem cell line constitutively over-
expressing L1, the speciﬁc pattern of glycosylation induced by L1
may also be an important factor in modulating ES cell survival
and proliferation. In agreement with this notion, we have con-
ﬁrmed that L1 promotes ES cell survival, and that this effect can
be blocked by shRNA knockdown of enzymes that mediate the
sialylation and fucosylation on the ESC surface. Thus, L1 may im-
prove cell survival by modulating cell surface sialylation and
fucosylation. Interestingly, sialylation of b1 integrins in colon can-
cer cell lines is reported to enhance survival by protecting against
galectin-3-induced apoptosis [23] and to increase resistance to
radiation-induced cell death [24]. It is intriguing to speculate that
Fig. 5. L1 inﬂuences FUT9, ST3Gal4 and ST6Gal1 mRNA levels via various intracellular signaling mediators. (A) One hour after passage of L1-transfected ESCs, inhibitors of
PLCc (U73122, 10.5 lM), CDC25 phosphatase (CDC25 inhibitor II, 1.05 lM), PI3 K (LY294002, 16.5 lM), Erk (Erk inhibitor, 50 lM) or PKA (KT5720, 280 nM) were added into
the culture medium and the cells were cultured for a further 24 h. Levels of FUT9, ST3Gal4 and ST6Gal1 mRNA were quantiﬁed by real-time PCR. (B) NIH3T3 cells were
transfected with empty vector (control: Cont) or shRNA of PLCc (PLCci) by electroporation. Twenty-four hours later, cells were lysed with RIPA buffer and total protein was
obtained. Western blot was used to detect the expression of PLCc. (C) The expression levels of ST6Gal1, ST3Gal4 and FUT9 mRNAs were detected with real-time PCR after L1-
ESCs were transfected with PLCc shRNAs (PLCci). *P < 0.05; **P < 0.001, by Student’s t-test.
Y.-L. Li et al. / FEBS Letters 583 (2009) 703–710 709L1-induced elevated sialylation or fucosylation at the cell surface
might have a similar effect by inhibiting the binding of pro-apop-
totic ligands to their cell surface receptors. Along the same line,
an increase in sialylation or fucosylation might trigger the interac-
tion between anti-apoptotic factors and their cell surface receptors.
Moreover, we have conﬁrmed that L1 reduces ES cell proliferation,
and that this effect can be reversed by shRNA knockdown of
enzymes that mediate the sialylation and fucosylation on the ESC
surface as well. Notably, in fucosylation-deﬁcient mice, a loss of
Notch-dependent signal transduction on myeloid progenitor cellswas observed, indicating that Notch-dependent control of myelo-
poiesis is regulated by fucosylation [25]. In addition, it was shown
that fucosylation of the epidermal growth factor receptor modu-
lated receptor activity as well as epidermal growth factor-medi-
ated cellular growth [26]. Similarly, in L1-overexpressing stem
cells, fucosylation of growth factor receptors could be increased,
reducing growth factor signaling and thereby cell proliferation.
However, the speciﬁc mechanisms by which the pattern of cell sur-
face sialylation and fucosylation induced in ESCs by L1 regulates
cell survival and cell proliferation remain to be determined.
710 Y.-L. Li et al. / FEBS Letters 583 (2009) 703–710All three enzymes upregulated by L1, FUT9, ST6Gal1 and
ST3Gal4, had similar effects on L1-dependent regulation of cell sur-
vival and proliferation. This observation suggests that both cellular
processes require glycosylation of cell surface proteins catalyzed
by each of the three enzymes. None of these modiﬁcations appears
to be dispensable either for regulation of cell growth or for sup-
porting cell survival, underscoring the importance of cell surface
glycosylation patterns for L1’s biological action.
The cell recognition molecule L1 activates a number of signal
transduction pathways, including PLCc-, PI3 K-, Erk- and PKA-
dependent pathways [1]. In order to clarify which of these path-
ways is responsible for the observed dysregulation of ST6Gal1,
ST3Gal4 and FUT9 expression, we applied several inhibitors of dif-
ferent intracellular signaling mediators. We have found that both
an inhibitor of PLCc and PLCc shRNA reduce FUT9, ST6Gal1, and
ST3Gal4 mRNA in L1-transfected ESCs. This suggests that L1 may
regulate both sialylation and fucosylation in relation to cell func-
tion via a common PLCc-dependent pathway. Moreover, an inhibi-
tion of extracellular signal-regulated kinase (ERK) might contribute
to the induction of glycosyltransferases by L1, as an ERK inhibitor
caused an increase in FUT9, ST6Gal1, and ST3Gal4 mRNA
expression.
The central dogma of molecular biology has been revised to in-
clude glycosylation or the attachment of glycans or carbohydrates
to proteins or to lipids, which provides for the needed functional
diversity to generate extensive phenotypes from a limited geno-
type [7]. Highly ordered, regulated, and conserved pathways of gly-
can diversiﬁcation have evolved to play speciﬁc biological roles,
many of which are essential and have persisted throughout mam-
malian speciation [27]. Recently, we have shown that cell surface
sialylation and fucosylation in neurons are regulated via PLCc by
L1, modulating neurite outgrowth, cell survival and migration
[28]. Together with the present study, we have further demon-
strated that L1 is also involved in induction of a speciﬁc glycosyla-
tion pattern at ESC surfaces, which in turn regulates ESC survival
and proliferation.
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